HEALTH● LOW2h ago · Sep 15, 2026, 8:21 AM
J&J reports phase 2b data on less-frequent lung cancer treatment
Seeking Alpha Tech · global
J&J has reported phase 2b data regarding a less-frequent treatment for lung cancer. This is a development in medical research that could impact future cancer therapies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoFears of catastrophic measles crisis grow as trust in lifesaving vaccines hits bottomThe Independent WorldHEALTH47m agoDoctors and nurses in Ceuta will strike on September 24 to protest working conditions aggravated by the crisisEl MundoHEALTH1h agoORIC (ORIC) Doubles Down On Prostate Cancer With Phase 3 LaunchYahoo FinanceHEALTH1h agoOutcome of employment lawsuit could promote use of skimpy health plansCBS News